TrialPH94B in the Treatment of Adjustment Disorder With Anxiety
Trial details
- Registry ID
- NCT04404192
- Phase
- Phase 2
Drug research
PH94B
Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.
Drug identity checked against registry records
Also recorded as Aloradine
A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.
Included trials
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| PH94B in the Treatment of Adjustment Disorder With AnxietyNCT04404192 | VTGN | Phase 2 | Completed | 2022-12-14Actual |
| Open-label Safety Trial of PH94B in Social Anxiety Disorder (SAD)NCT05030350 | VTGN | Phase 3 | Terminated | 2022-09-23Actual |
Open-label Safety Trial of PH94B in Social Anxiety Disorder (SAD)
Trial details
- Registry ID
- NCT05030350
- Phase
- Phase 3
Regulatory dates and decisions
| No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed. |